Athnaiel Onella, Cantillo Santiago, Paredes Stephania, Knezevic Nebojsa Nick
Department of Anesthesiology, Advocate Illinois Masonic Medical Center, Chicago, IL 60657, USA.
Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL 60064, USA.
Int J Mol Sci. 2023 Jan 18;24(3):1866. doi: 10.3390/ijms24031866.
Millions of people are affected by pain-related conditions worldwide. Literature has consistently shown that each individual experiences and perceives pain in a unique manner due to biological, environmental, and cultural factors in which they have been raised. It has been established that biological males and females perceive pain differently and that it may be partially explained by their distinct hormonal profiles since birth, which are only further magnified during puberty. For biological males, high levels of testosterone have shown to increase their pain threshold; and for biological females, estrogen fluctuations have shown to increase pain intensity and perception. However, sex hormones have not been studied in the context of pain treatment or their impact on biochemical pathways involved in pain perception. For this purpose, the transgender community serves as a unique population to investigate the impact of hormone replacement therapy on molecular pathways involved in the perception of pain. The purpose of this review is to explore the biochemistry of hormone replacement in transgender patients who also have other pain-related conditions such as headaches, fibromyalgia, temporomandibular myalgia, and visceral pain.
全球数百万人受到与疼痛相关病症的影响。文献一直表明,由于成长过程中的生物、环境和文化因素,每个人体验和感知疼痛的方式都是独特的。已经确定,生理上的男性和女性对疼痛的感知不同,这可能部分归因于他们自出生起就不同的激素水平,而这种差异在青春期会进一步放大。对于生理男性,高水平的睾酮已被证明会提高他们的疼痛阈值;对于生理女性,雌激素波动已被证明会增加疼痛强度和疼痛感。然而,性激素在疼痛治疗背景下或其对疼痛感知所涉及的生化途径的影响尚未得到研究。为此,跨性别群体是一个独特的人群,可用于研究激素替代疗法对疼痛感知所涉及分子途径的影响。本综述的目的是探讨同时患有其他与疼痛相关病症(如头痛、纤维肌痛、颞下颌肌痛和内脏疼痛)的跨性别患者激素替代的生物化学。